Company · CIK 0001714899
Denali Therapeutics Inc.
DNLISearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$18.58+$0.54 (+2.99%)
DNLI · Last trade
- Prev close
- $18.04
- Range (29d)
- $17.61 – $21.60
On the record
Recent filings
- 144DNLIDenali Therapeutics Inc.0002124755-26-000006 · 4.8 KBSEC(opens sec.gov)
- 144DNLIDenali Therapeutics Inc.0001950047-26-009017 · 5.0 KBSEC(opens sec.gov)
- 144DNLIDenali Therapeutics Inc.0001950047-26-008944 · 4.8 KBSEC(opens sec.gov)
- 144DNLIDenali Therapeutics Inc.0001724311-26-000012 · 4.8 KBSEC(opens sec.gov)
- 10-QDNLIQuarterly update0001714899-26-000097 · 6.8 MBSEC(opens sec.gov)
- 8-KDNLICurrent report0001714899-26-000096 · 325.9 KBSEC(opens sec.gov)
- SCHEDULE 13G/ADNLIDenali Therapeutics Inc.0001088875-26-000056 · 7.7 KBSEC(opens sec.gov)
- 8-KDNLICurrent report0001714899-26-000086 · 161.8 KBSEC(opens sec.gov)
- 8-KDNLICurrent report0001714899-26-000081 · 221.7 KBSEC(opens sec.gov)
- 8-KDNLICurrent report0001714899-26-000070 · 244.7 KBSEC(opens sec.gov)
Insiders
- 667, L.P.Director
- AFEYAN NOUBAR10% Owner
- ARCH Venture Fund VIII, L.P.10% Owner
- ARCH Venture Partners VIII, LLC10% Owner
- ARCH Venture Partners VIII, L.P.10% Owner
- Baker Bros. Advisors (GP) LLCDirector
- BAKER BROS. ADVISORS LPDirector
- Baker Brothers Life Sciences LPDirector
- BAKER FELIXDirector
- BAKER JULIANDirector
Tickers
Addresses
business
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA, 94080
mailing
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA, 94080
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies